Barnes Pettey Financial Advisors’s AbbVie ABBV Stock Holding History

Barnes Pettey Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$539K	Sell	2,142 -15	-0.7%	-$3.23K	0.17%	101
2026 Q1	$469K	Sell	2,157 -12	-0.6%	-$2.66K	0.2%	93
2025 Q4	$496K	Hold	2,169	–	–	0.25%	77
2025 Q3	$502K	Buy	+2,169	New	+$442K	0.28%	66
2022 Q3	–	Sell	-4,771	Closed	-$731K	–	86
2022 Q2	$731K	Buy	4,771 +20	+0.4%	+$3.06K	0.94%	29
2022 Q1	$770K	Hold	4,751	–	–	0.93%	27
2021 Q4	$643K	Buy	+4,751	New	+$561K	0.74%	36

Other funds holding ABBV

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Barnes Pettey Financial Advisors's ABBV Position: Q2 2026 in Review

Barnes Pettey Financial Advisors reduced its AbbVie (ABBV) stake by 0.7% in Q2 2026, selling an estimated $3.23K and leaving 2,142 shares worth $539K. The position accounts for 0.17% of the portfolio, ranked #101.

Barnes Pettey Financial Advisors first reported a position in ABBV in Q4 2021 and has held it in 7 quarters since. The position peaked at $770K in Q1 2022. 2,345 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Barnes Pettey Financial Advisors held 2,142 shares of AbbVie worth $539K as of Q2 2026.
Barnes Pettey Financial Advisors sold 15 AbbVie shares in Q2 2026, an estimated $3.23K.
AbbVie made up 0.17% of Barnes Pettey Financial Advisors's portfolio in Q2 2026, its #101 holding.
Barnes Pettey Financial Advisors first reported a position in AbbVie in Q4 2021 and has held it in 7 quarters since.
Barnes Pettey Financial Advisors's AbbVie position peaked at $770K in Q1 2022.
2,345 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Barnes Pettey Financial Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.